Mobile

Safety of the Inactivated, Split-Virion Influenza Vaccine Administered by the Intradermal Route in Healthy Children

Mise à jour : Il y a 4 ans
Référence : EUCTR2005-002965-35

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To describe the safety of the 9µg formulation of the inactivated, split-virion influenza vaccine administered by the intradermal (ID) route in children aged 6 to 35 months and 3 to 8 years.

Critère d'inclusion

  • Vaccination of healthy children aged 6 to 35 months and 3 to 8 years (2 doses at a 28 day-interval)

Liens